{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:03:27Z","timestamp":1791561807318,"version":"4.3.4"},"reference-count":119,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.pain.2007.08.033","type":"journal-article","created":{"date-parts":[[2007,11,10]],"date-time":"2007-11-10T07:15:37Z","timestamp":1194678937000},"page":"237-251","source":"Crossref","is-referenced-by-count":1688,"title":["Pharmacologic management of neuropathic pain: Evidence-based recommendations"],"prefix":"10.1097","volume":"132","author":[{"given":"Robert H.","family":"Dworkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec B.","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Backonja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanna B.","family":"Finnerup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troels S.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eija A.","family":"Kalso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Loeser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Miaskowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turo J.","family":"Nurmikko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell K.","family":"Portenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.C.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett R.","family":"Stacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf-Detlef","family":"Treede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis C.","family":"Turk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210126","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jpainsymman.2005.10.006","article-title":"A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain.","volume":"31","author":"Adams","year":"2006","journal-title":"J Pain Symptom Manage"},{"key":"R2-6-20210126","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00000542-200603000-00025","article-title":"Opioid-induced hyperalgesia: a qualitative systematic review.","volume":"104","author":"Angst","year":"2006","journal-title":"Anesthesiology"},{"key":"R3-6-20210126","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","article-title":"EFNS guidelines on pharmacological treatment of neuropathic pain.","volume":"13","author":"Attal","year":"2006","journal-title":"Eur J Neurol"},{"key":"R4-6-20210126","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","article-title":"Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus.","volume":"280","author":"Backonja","year":"1998","journal-title":"JAMA"},{"key":"R5-6-20210126","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0149-2918(03)90011-7","article-title":"Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials.","volume":"25","author":"Backonja","year":"2003","journal-title":"Clin Ther"},{"key":"R6-6-20210126","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pain.2007.03.028","article-title":"Opioid dependence and addiction during opioid treatment of chronic pain.","volume":"129","author":"Ballantyne","year":"2007","journal-title":"Pain"},{"key":"R8-6-20210126","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1600-0404.2006.00631.x","article-title":"Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study.","volume":"113","author":"Beydoun","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"R10-6-20210126","first-page":"481","article-title":"Gabapentin in postamputation phantom limb pain: a randomized, double-blind, placebo-controlled, cross-over study.","volume":"27","author":"Bone","year":"2002","journal-title":"Reg Anesth Pain Med"},{"key":"R11-6-20210126","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0304-3959(03)00020-4","article-title":"Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial.","volume":"104","author":"Boureau","year":"2003","journal-title":"Pain"},{"key":"R12-6-20210126","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1090-3801(99)90015-0","article-title":"The lifetime occurrence of herpes zoster and prevalence of postherpetic neuralgia: a retrospective survey in an elderly population.","volume":"3","author":"Bowsher","year":"1999","journal-title":"Eur J Pain"},{"key":"R14-6-20210126","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1200\/JCO.2004.08.141","article-title":"Gabapentin for neuropathic cancer pain: a randomized controlled trial from the gabapentin cancer pain study group.","volume":"22","author":"Caraceni","year":"2004","journal-title":"J Clin Oncol"},{"key":"R15-6-20210126","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0304-3959(01)00483-3","article-title":"Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial.","volume":"96","author":"Cardenas","year":"2002","journal-title":"Pain"},{"key":"R16-6-20210126","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.mcna.2006.10.003","article-title":"Opioid tolerance and hyperalgesia.","volume":"91","author":"Chang","year":"2007","journal-title":"Med Clin North Am"},{"key":"R17-6-20210126","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jpain.2005.08.001","article-title":"Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study.","volume":"7","author":"Chu","year":"2006","journal-title":"J Pain"},{"key":"R18-6-20210126","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/pds.1113","article-title":"Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994-2004.","volume":"14","author":"Cicero","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R19-6-20210126","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0002-9343(99)00301-0","article-title":"Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents.","volume":"108","author":"Cohen","year":"2000","journal-title":"Am J Med"},{"key":"R20-6-20210126","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1468-1331.2004.00791.x","article-title":"EFNS guidelines on neuropathic pain assessment.","volume":"11","author":"Cruccu","year":"2004","journal-title":"Eur J Neurol"},{"key":"R21-6-20210126","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1054\/jpai.2002.126790","article-title":"Hypogonadism in men consuming sustained-action oral opioids.","volume":"3","author":"Daniell","year":"2002","journal-title":"J Pain"},{"key":"R22-6-20210126","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ejpain.2004.11.006","article-title":"Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study.","volume":"9","author":"Dogra","year":"2005","journal-title":"Eur J Pain"},{"key":"R23-6-20210126","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.curtheres.2005.12.003","article-title":"Clinical consequences of initial duloxetine dosing strategies: comparison of 30 and 60 mg QD starting doses.","volume":"66","author":"Dunner","year":"2005","journal-title":"Curr Ther Res"},{"key":"R25-6-20210126","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archneur.60.11.1524","article-title":"Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.","volume":"60","author":"Dworkin","year":"2003","journal-title":"Arch Neurol"},{"key":"R26-6-20210126","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/01.WNL.0000055433.55136.55","article-title":"Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial.","volume":"60","author":"Dworkin","year":"2003","journal-title":"Neurology"},{"key":"R27-6-20210126","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1001\/jama.293.24.3043","article-title":"Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials.","volume":"293","author":"Eisenberg","year":"2005","journal-title":"JAMA"},{"key":"R28-6-20210126","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1097\/00126334-200412150-00010","article-title":"A randomized controlled trial of 5 lidocaine gel for HIV-associated distal symmetric polyneuropathy.","volume":"37","author":"Estanislao","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R29-6-20210126","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1176\/ajp.154.12.1760","article-title":"Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine.","volume":"154","author":"Fava","year":"1997","journal-title":"Am J Psychiatry"},{"key":"R30-6-20210126","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1351-5101.2003.00725.x","article-title":"Spinal cord injury pain: mechanisms and treatment.","volume":"11","author":"Finnerup","year":"2004","journal-title":"Eur J Neurol"},{"key":"R31-6-20210126","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","article-title":"Algorithm for neuropathic pain treatment: an evidence based proposal.","volume":"118","author":"Finnerup","year":"2005","journal-title":"Pain"},{"key":"R32-6-20210126","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pain.2005.02.032","article-title":"Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens.","volume":"115","author":"Freynhagen","year":"2005","journal-title":"Pain"},{"key":"R33-6-20210126","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1503\/cmaj.051528","article-title":"Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects.","volume":"174","author":"Furlan","year":"2006","journal-title":"CMAJ"},{"key":"R34-6-20210126","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0304-3959(98)00244-9","article-title":"Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study.","volume":"80","author":"Galer","year":"1999","journal-title":"Pain"},{"key":"R35-6-20210126","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1345\/aph.1A185","article-title":"Pharmacokinetics and tolerability of lidocaine patch 5 with extended dosing.","volume":"36","author":"Gammaitoni","year":"2002","journal-title":"Ann Pharmacother"},{"key":"R36-6-20210126","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin, or their combination for neuropathic pain.","volume":"352","author":"Gilron","year":"2005","journal-title":"N Engl J Med"},{"key":"R37-6-20210126","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/01.WNL.0000057720.36503.2C","article-title":"Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial.","volume":"60","author":"Gimbel","year":"2003","journal-title":"Neurology"},{"key":"R38-6-20210126","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pain.2005.03.029","article-title":"Duloxetine vs. placebo in patients with painful diabetic neuropathy.","volume":"116","author":"Goldstein","year":"2005","journal-title":"Pain"},{"key":"R39-6-20210126","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/jnnp.66.2.251","article-title":"Gabapentin in the treatment of painful diabetic neuropathy: a placebo-controlled, double-blind, crossover trial.","volume":"66","author":"Gorson","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R40-6-20210126","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.jpain.2006.01.128","article-title":"Double-blind, placebo-controlled trial of add-on lamotrigine in patients with neuropathic pain and inadequate relief with gabapentin, TCAs or non-narcotic analgesics.","volume":"7","author":"Grainger","year":"2006","journal-title":"J Pain"},{"key":"R41-6-20210126","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1600-0404.2005.00559.x","article-title":"A randomized, placebo-controlled study of oxcarbazepine in painful diabetic neuropathy.","volume":"114","author":"Grosskopf","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"R42-6-20210126","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1592\/phco.24.6.621.34748","article-title":"Treatment of pain syndromes with venlafaxine.","volume":"24","author":"Grothe","year":"2004","journal-title":"Pharmacotherapy"},{"key":"R43-6-20210126","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/s00415-004-0529-6","article-title":"A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies.","volume":"251","author":"Hahn","year":"2004","journal-title":"J Neurol"},{"key":"R44-6-20210126","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pain.2006.01.030","article-title":"Epidemiology and treatment of neuropathic pain: the UK primary care perspective.","volume":"122","author":"Hall","year":"2006","journal-title":"Pain"},{"key":"R45-6-20210126","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0304-3959(02)00047-7","article-title":"Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy.","volume":"98","author":"Hammack","year":"2002","journal-title":"Pain"},{"key":"R46-6-20210126","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.pain.2004.10.007","article-title":"Pharmacological treatment of peripheral neuropathic conditions based on shared commonalities despite multiple etiologies.","volume":"113","author":"Hansson","year":"2005","journal-title":"Pain"},{"key":"R48-6-20210126","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1212\/WNL.50.6.1842","article-title":"Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy.","volume":"50","author":"Harati","year":"1998","journal-title":"Neurology"},{"key":"R49-6-20210126","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2337\/dc06-0947","article-title":"Does treatment with duloxetine for neuropathic pain impact glycemic control?","volume":"30","author":"Hardy","year":"2007","journal-title":"Diabetes Care"},{"key":"R50-6-20210126","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1371\/journal.pmed.0020164","article-title":"Analgesic therapy in postherpetic neuralgia: a quantitative systematic review.","volume":"2","author":"Hempenstall","year":"2005","journal-title":"PLoS Med"},{"key":"R51-6-20210126","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/bmj.323.7314.666","article-title":"Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care.","volume":"323","author":"Hippisley-Cox","year":"2001","journal-title":"BMJ"},{"key":"R52-6-20210126","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ejpain.2006.08.004","article-title":"Addiction to opioids in chronic pain patients: a literature review.","volume":"11","author":"Hojsted","year":"2007","journal-title":"Eur J Pain"},{"key":"R54-6-20210126","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0304-3959(00)00385-7","article-title":"The effect of opioids on phantom limb pain and cortical reorganization.","volume":"90","author":"Huse","year":"2001","journal-title":"Pain"},{"key":"R55-6-20210126","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1472-6963-6-46","article-title":"Predictors of opioid misuse in patients with chronic pain: prospective cohort study.","volume":"6","author":"Ives","year":"2006","journal-title":"BMC Health Serv Res"},{"key":"R56-6-20210126","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1212\/01.wnl.0000259085.61898.9e","article-title":"The impact of neuropathic pain on health-related quality of life: review and implications.","volume":"68","author":"Jensen","year":"2007","journal-title":"Neurology"},{"key":"R57-6-20210126","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1155\/2003\/436716","article-title":"Use of opioid analgesics for the treatment of chronic noncancer pain: a consensus statement and guidelines from the Canadian Pain Society, 2002.","volume":"8","author":"Jovey","year":"2003","journal-title":"Pain Res Manage"},{"key":"R58-6-20210126","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1090-3801(02)00143-X","article-title":"Recommendations for using opioids in chronic non-cancer pain.","volume":"7","author":"Kalso","year":"2003","journal-title":"Eur J Pain"},{"key":"R59-6-20210126","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/01.ajp.0000210953.86255.8f","article-title":"Foundations of opioid risk management.","volume":"23","author":"Katz","year":"2007","journal-title":"Clin J Pain"},{"key":"R60-6-20210126","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pain.2006.10.029","article-title":"Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain.","volume":"130","author":"Khoromi","year":"2007","journal-title":"Pain"},{"key":"R61-6-20210126","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jpain.2005.08.002","article-title":"Topiramate in chronic lumbar radicular pain.","volume":"6","author":"Khoromi","year":"2005","journal-title":"J Pain"},{"key":"R62-6-20210126","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1212\/WNL.51.6.1682","article-title":"A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection.","volume":"51","author":"Kieburtz","year":"1998","journal-title":"Neurology"},{"key":"R63-6-20210126","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1212\/01.WNL.0000145767.36287.A1","article-title":"Pregabalin relieves symptoms of painful diabetic neuropathy.","volume":"63","author":"Lesser","year":"2004","journal-title":"Neurology"},{"key":"R64-6-20210126","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/01.BRS.0000112068.16108.3A","article-title":"O, Ozerbil O, Ogun TC, Ugurlu H. Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury.","volume":"29","author":"Levendoglu","year":"2004","journal-title":"Spine"},{"key":"R66-6-20210126","first-page":"215","article-title":"Controlled substance abuse and illicit drug use in chronic pain patients: an evaluation of multiple variables.","volume":"9","author":"Manchikanti","year":"2006","journal-title":"Pain Physician"},{"key":"R67-6-20210126","doi-asserted-by":"crossref","first-page":"116","DOI":"10.7326\/0003-4819-146-2-200701160-00006","article-title":"Opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction.","volume":"146","author":"Martell","year":"2007","journal-title":"Ann Intern Med"},{"key":"R68-6-20210126","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1136\/bmj.38042.506748.EE","article-title":"Systematic review of topical capsaicin for the treatment of chronic pain.","volume":"328","author":"Mason","year":"2004","journal-title":"BMJ"},{"key":"R69-6-20210126","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.37.4.589","article-title":"Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood.","volume":"37","author":"Max","year":"1987","journal-title":"Neurology"},{"key":"R70-6-20210126","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJM199205073261904","article-title":"Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.","volume":"326","author":"Max","year":"1992","journal-title":"N Engl J Med"},{"key":"R71-6-20210126","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00482-003-0272-4","article-title":"Reduktion chronischer Schmerzen bei nichtpostherpetischen peripheren Neuropathien nach topischer Behandlung mit Lidocainpflaster.","volume":"18","author":"Meier","year":"2004","journal-title":"Schmerz"},{"key":"R72-6-20210126","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3959(03)00317-8","article-title":"Efficacy of lidocaine patch 5 in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study.","volume":"106","author":"Meier","year":"2003","journal-title":"Pain"},{"key":"R73-6-20210126","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/030089160208800310","article-title":"Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study.","volume":"88","author":"Mercadante","year":"2002","journal-title":"Tumori"},{"key":"R75-6-20210126","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/eujp.2001.0259","article-title":"Peripheral neuropathic pain: a multidimensional burden for patients.","volume":"5","author":"Meyer-Rosberg","year":"2001","journal-title":"Eur J Pain"},{"key":"R76-6-20210126","doi-asserted-by":"crossref","first-page":"771","DOI":"10.4088\/JCP.v67n0511","article-title":"Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine.","volume":"67","author":"Montgomery","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R77-6-20210126","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1191\/0269216303pm815oa","article-title":"Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial.","volume":"17","author":"Morley","year":"2003","journal-title":"Palliat Med"},{"key":"R79-6-20210126","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1097\/00000539-200212000-00046","article-title":"Gabapentin for the treatment of pain in Guillain-Barre syndrome: a double-blinded, placebo-controlled, crossover study.","volume":"95","author":"Pandey","year":"2002","journal-title":"Anesth Analg"},{"key":"R80-6-20210126","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1212\/WNL.59.7.1015","article-title":"Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial.","volume":"59","author":"Raja","year":"2002","journal-title":"Neurology"},{"key":"R81-6-20210126","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/cncr.20028","article-title":"Symptomatic hypogonadism in male survivors of cancer with chronic exposure to morphine.","volume":"100","author":"Rajagopal","year":"2004","journal-title":"Cancer"},{"key":"R82-6-20210126","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1526-4637.2005.00061.x","article-title":"A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.","volume":"6","author":"Raskin","year":"2005","journal-title":"Pain Med"},{"key":"R83-6-20210126","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/jpm.2006.9.29","article-title":"Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain.","volume":"9","author":"Raskin","year":"2006","journal-title":"J Palliat Med"},{"key":"R84-6-20210126","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1212\/01.WNL.0000137341.89781.14","article-title":"Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects.","volume":"63","author":"Raskin","year":"2004","journal-title":"Neurology"},{"key":"R85-6-20210126","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.pain.2004.04.034","article-title":"Symptoms and signs in patients with suspected neuropathic pain.","volume":"100","author":"Rasmussen","year":"2004","journal-title":"Pain"},{"key":"R86-6-20210126","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.clpt.2003.09.019","article-title":"Cyclic antidepressants and the risk of sudden cardiac death.","volume":"75","author":"Ray","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"R87-6-20210126","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0304-3959(01)00407-9","article-title":"Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study.","volume":"94","author":"Rice","year":"2001","journal-title":"Pain"},{"key":"R89-6-20210126","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpain.2004.12.007","article-title":"Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial.","volume":"6","author":"Richter","year":"2005","journal-title":"J Pain"},{"key":"R90-6-20210126","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archpsyc.62.9.1022","article-title":"Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.","volume":"62","author":"Rickels","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"R91-6-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.apmr.2004.04.001","article-title":"Trial of amitriptyline for relief of pain in amputees: results of a randomized controlled study.","volume":"85","author":"Robinson","year":"2004","journal-title":"Arch Phys Med Rehabil"},{"key":"R92-6-20210126","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jama.279.4.287","article-title":"Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.","volume":"279","author":"Roose","year":"1998","journal-title":"JAMA"},{"key":"R93-6-20210126","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pain.2004.05.001","article-title":"Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial.","volume":"110","author":"Rosenstock","year":"2004","journal-title":"Pain"},{"key":"R94-6-20210126","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/ana.410370216","article-title":"Topical lidocaine gel relieves postherpetic neuralgia.","volume":"37","author":"Rowbotham","year":"1995","journal-title":"Ann Neurol"},{"key":"R95-6-20210126","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0304-3959(95)00146-8","article-title":"Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia.","volume":"65","author":"Rowbotham","year":"1996","journal-title":"Pain"},{"key":"R96-6-20210126","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.pain.2004.05.010","article-title":"Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study.","volume":"100","author":"Rowbotham","year":"2004","journal-title":"Pain"},{"key":"R97-6-20210126","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/jama.280.21.1837","article-title":"Gabapentin for the treatment postherpetic neuralgia: a randomized controlled trial.","volume":"280","author":"Rowbotham","year":"1998","journal-title":"JAMA"},{"key":"R98-6-20210126","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jpain.2005.07.001","article-title":"Treatment response in antidepressant-naive postherpetic neuralgia patients: double-blind, randomized trial.","volume":"6","author":"Rowbotham","year":"2005","journal-title":"J Pain"},{"key":"R99-6-20210126","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMoa021420","article-title":"Oral opioid therapy for chronic peripheral and central neuropathic pain.","volume":"348","author":"Rowbotham","year":"2003","journal-title":"N Engl J Med"},{"key":"R101-6-20210126","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2004.01.001","article-title":"Pregabalin reduces pain and improved sleep and mood disturbances in patients with postherpetic neuralgia: results of a randomised, placebo-controlled clinical trial.","volume":"109","author":"Sabatowski","year":"2004","journal-title":"Pain"},{"key":"R102-6-20210126","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00002508-200211000-00002","article-title":"The epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy.","volume":"18","author":"Schmader","year":"2002","journal-title":"Clin J Pain"},{"key":"R103-6-20210126","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/0269881105049040","article-title":"Cannabis as a risk factor for psychosis: systematic review.","volume":"19","author":"Semple","year":"2005","journal-title":"J Psychopharmacol"},{"key":"R104-6-20210126","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0304-3959(02)00255-5","article-title":"Gabapentin in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial.","volume":"99","author":"Serpell","year":"2002","journal-title":"Pain"},{"key":"R105-6-20210126","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1001\/jama.280.18.1590","article-title":"Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial.","volume":"280","author":"Shlay","year":"1998","journal-title":"JAMA"},{"key":"R106-6-20210126","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1212\/01.wnl.0000244422.45278.ff","article-title":"Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial.","volume":"67","author":"Siddall","year":"2006","journal-title":"Neurology"},{"key":"R107-6-20210126","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3959(99)00079-2","article-title":"Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial.","volume":"83","author":"Sindrup","year":"1999","journal-title":"Pain"},{"key":"R108-6-20210126","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/01.WNL.0000058749.49264.BD","article-title":"Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial.","volume":"60","author":"Sindrup","year":"2003","journal-title":"Neurology"},{"key":"R109-6-20210126","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1742-7843.2005.pto_96696601.x","article-title":"Antidepressants in the treatment of neuropathic pain.","volume":"96","author":"Sindrup","year":"2005","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"R110-6-20210126","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1682\/JRRD.2005.05.0082","article-title":"Efficacy of gabapentin in treating chronic phantom limb and residual limb pain.","volume":"42","author":"Smith","year":"2005","journal-title":"J Rehabil Res Dev"},{"key":"R111-6-20210126","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/10790268.2002.11753609","article-title":"Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized double-blind, crossover trial.","volume":"25","author":"Tai","year":"2002","journal-title":"J Spinal Cord Med"},{"key":"R112-6-20210126","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/eujp.2001.0266","article-title":"Venlafaxine in neuropathic pain following treatment of breast cancer.","volume":"6","author":"Tasmuth","year":"2002","journal-title":"Eur J Pain"},{"key":"R113-6-20210126","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/hrt.2004.037457","article-title":"General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial, infarction.","volume":"91","author":"Tata","year":"2005","journal-title":"Heart"},{"key":"R114-6-20210126","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1527-3458.2004.tb00012.x","article-title":"The biology and pharmacology of calcium channel 2- proteins.","volume":"10","author":"Taylor","year":"2004","journal-title":"CNS Drug Rev"},{"key":"R116-6-20210126","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.jcp.0000155815.44338.95","article-title":"Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine.","volume":"25","author":"Thase","year":"2005","journal-title":"J Clin Psychopharm"},{"key":"R118-6-20210126","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-0404.2004.00338.x","article-title":"Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials.","volume":"110","author":"Thienel","year":"2004","journal-title":"Acta Neurol Scand"},{"key":"R119-6-20210126","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1213\/01.ANE.0000186348.86792.38","article-title":"Systemic administration of local anesthetic agents to relieve neuropathic pain: a systematic review and meta-analysis.","volume":"101","author":"Tremont-Lukats","year":"2005","journal-title":"Anesth Analg"},{"key":"R120-6-20210126","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.mjt.0000132250.95650.85","article-title":"Opioid therapy and immunosuppression: a review.","volume":"11","author":"Vallejo","year":"2004","journal-title":"Am J Ther"},{"key":"R122-6-20210126","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1185\/030079906X80404","article-title":"Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial.","volume":"22","author":"van Seventer","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"R123-6-20210126","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pain.2006.09.040","article-title":"Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized double-blind, placebo-controlled studies.","volume":"128","author":"Vinik","year":"2007","journal-title":"Pain"},{"key":"R124-6-20210126","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/WNL.50.6.1837","article-title":"Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia.","volume":"50","author":"Watson","year":"1998","journal-title":"Neurology"},{"key":"R125-6-20210126","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0304-3959(03)00160-X","article-title":"Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy.","volume":"105","author":"Watson","year":"2003","journal-title":"Pain"},{"key":"R126-6-20210126","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1212\/WNL.51.4.1166","article-title":"Nortriptyline versus amitriptyline in postherpetic neuralgia: a randomized trial.","volume":"51","author":"Watson","year":"1998","journal-title":"Neurology"},{"key":"R127-6-20210126","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1155\/2004\/304094","article-title":"Chronic noncancer pain and the long term utility of opioids.","volume":"9","author":"Watson","year":"2004","journal-title":"Pain Res Manage"},{"key":"R128-6-20210126","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1212\/01.wnl.0000240225.04000.1a","article-title":"A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.","volume":"67","author":"Wernicke","year":"2006","journal-title":"Neurology"},{"key":"R130-6-20210126","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00000542-200509000-00027","article-title":"Postamputation pain and sensory changes in treatment-naive patients: characteristics and responses to treatment with tramadol, amitriptyline, and placebo.","volume":"103","author":"Wilder-Smith","year":"2005","journal-title":"Anesthesiology"},{"key":"R131-6-20210126","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/00000542-200603000-00028","article-title":"Postoperative analgesia: its clinical importance and relevance.","volume":"104","author":"Wilder-Smith","year":"2006","journal-title":"Anesthesiology"},{"key":"R133-6-20210126","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ejpain.2004.09.009","article-title":"The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study.","volume":"9","author":"Yucel","year":"2005","journal-title":"Eur J Pain"},{"key":"R134-6-20210126","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.drugalcdep.2005.05.007","article-title":"Profiling the subjective, psychomotor, and physiological effects of tramadol in recreational drug users.","volume":"80","author":"Zacny","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"R135-6-20210126","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0376-8716(03)00003-6","article-title":"College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: position statement.","volume":"69","author":"Zacny","year":"2003","journal-title":"Drug Alcohol Depend"}],"container-title":["Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006396-200712050-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:54:33Z","timestamp":1786035273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006396-200712050-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":119,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1016\/j.pain.2007.08.033","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1116530.572565","asserted-by":"object"}]},"ISSN":["0304-3959"],"issn-type":[{"value":"0304-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}